Mobile Menu
Notes From The Consultant Pharmacists

Notes From The Consultant Pharmacists

  • PPIs – Not As Safe As We Thought

    While Proton Pump Inhibitors (PPIs) are very effective in acid reduction and with gastric and peptic ulcers, recent issues have surfaced. When PPIs first came out they were thought to be safe. As a result, they were approved for OTC use. Now, however, they are linked to many undesirable side effects as well as a higher rate of dementia and even MIs or GI cancer. The most recent revision of American Geriatric Society’s (AGS) Beers criteria strongly recommends against using PPIs beyond eight weeks.

    Read More
  • Falls—Which Medications To Avoid

    Falls are a traumatic experience, frequently leading to fractures, hospitalization, immobility and depression. Although some falls are mechanical in nature, others can be caused by excessive doses of medication or polypharmacy (multiple medications).

    Read More
  • Important Changes To Sliding Scale Insulin Use

    In the coming months, you will see a greater focus on sliding scale insulin (SSI) use. Minnesota Department of Health survey teams have been trained to evaluate SSI usage but, for many reasons, it has been determined that facilities should try to avoid or at least limit the use of SSI in long-term care.

    Read More
  • The Proper Timing of Levothyroxine

    Levothyroxine administration has been a recent focus of Minnesota Department of Health surveys resulting in the following implications and recommendations: Levothyroxine absorption is highly dependent on time and relation to meals. Absorption could range from 40% to 80% depending on administration time.

    Read More

For more news and information about our industry, please visit the websites below:

Contact us today at 844-637-9461 (844-MERWIN1) or info@MerwinLTC.com to learn how we help revitalize the patient experience.